


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.23%
-1.87%
+0.90%
+1.26%
OSCR
Oscar Health
$13.23
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value
OSCR Price Performance
$15.7 (-15.73%)
$16.73 (-20.92%)
$19.13 (-30.84%)
$15.53 (-14.81%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Loss widens YoY
Reported a weak earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
OSCR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
OSCR Street Sentiment is bullish and have positive views on the near-term outlook
OSCR has Fair risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 11, 2026
Upgrade
Neutral
UBS
Jan 10, 2026
Upgrade
Neutral
UBS
Dec 11, 2025
Upgrade
Overweight
Piper Sandler
What is OSCR current stock price?
What are OSCR stock strengths?
What is OSCR Risk Level?
What is OSCR market cap and volume?
What is OSCR current Stock IQ?
Should I buy OSCR stock right now?
Is OSCR a Strong Buy right now?
What does a 'Strong Buy' rating mean for OSCR?
What does a 'Strong Sell' rating mean for OSCR?
What factors influence OSCR's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
OSCR
Oscar Health
Current Price
$13.23

OSCR Price Performance
$15.7 (-15.73%)
$16.73 (-20.92%)
$19.13 (-30.84%)
$15.53 (-14.81%)
OSCR Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Loss widens YoY
Reported a weak earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
OSCR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
OSCR Street Sentiment is bullish and have positive views on the near-term outlook
OSCR has Fair risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
OSCR Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value
OSCR Latest Analysis
Oscar Health: Macro Headwinds Hurt In 2025 Are Expected. Eyes On Massive Price Discovery In 2026.
Fri Feb 13, 2026
Raymond James Upgrade Boosts Oscar Health Stock After Q4 Earnings. ) shares are climbing on Thursday. The company posted fourth‑quarter results that missed expectations on both revenue and earnings but had a .Oscar Health stock is gaining positive traction. Oscar reported a quarterly loss of $1.24 per share wider than the 89 cent loss analysts were expecting and a notable step back from the 62 cent loss a year ago. Revenue also came in light at $2.81 billion below the $3.12 billion consensus tho
Thu Feb 12, 2026
Raymond James upgrades Oscar Health on valuation and margin recovery outlook.
Thu Feb 12, 2026
Oscar Health Q4: Tricky 2025 Promising 2026 - Long-Term Thesis Attractive.
Wed Feb 11, 2026
Oscar Health Inc. (OSCR) Upgraded as Valuation Appears Balanced. We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 9 UBS upgraded Oscar Health Inc. (NYSE:OSCR) to Neutral from Sell and raised its price target to $17 from $12. The firm cited better-than-expected exchange enrollment trends despite the expiration of enhanced subsidies and noted that the shares appear [….]
Wed Feb 11, 2026
Oscar Health Stock Is a Screaming Buy Right Now. In this video I will cover Oscar Healths (NYSE: OSCR) recent earnings report and call. Watch the short video to learn more consider subscribing and click the special offer link below.
Wed Feb 11, 2026
Is Down 7.4% After Wider 2025 Losses But Confident 2026 Profit Outlook. Oscar Health Inc. has already reported its Q4 and full-year 2025 results with net loss widening to US$352.61 million for the quarter and US$443.15 million for the year alongside a basic loss per share of US$1.24 in Q4 and US$1.69 for 2025.-Despite the larger losses and an earnings miss Oscar
Wed Feb 11, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
OSCR Stock trends
OSCR Stock performance
OSCR Stock analysis
OSCR investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.